The ADC binds HER2 on target cells, is internalized, and releases the topoisomerase I inhibitor deruxtecan (DXd), causing Top1-mediated DNA damage/replication arrest and apoptosis; the antibody Fc can also trigger ADCC, with some bystander killing.